Ono Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	188,385	204,567	166,141	96,135	69,112	61,045
Short-Term Investments	60	4,479	-	20	60	2,978
Cash & Short-Term Investments	188,445	209,046	166,141	96,155	69,172	64,023
Cash Growth	10.30%	25.82%	72.78%	39.01%	8.04%	-8.04%
Receivables	149,485	135,022	136,066	114,396	99,788	84,269
Inventory	66,095	74,864	48,629	44,814	41,817	39,151
Prepaid Expenses	-	20,670	14,699	10,465	10,952	10,003
Other Current Assets	29,244	15,502	48,061	79,271	59,537	50,196
Total Current Assets	433,269	455,104	413,596	345,101	281,266	247,642
Property, Plant & Equipment	101,702	105,721	104,752	108,420	112,131	113,866
Long-Term Investments	97,088	100,975	297,170	324,178	255,997	281,393
Goodwill	22,183	21,186	-	-	-	-
Other Intangible Assets	369,156	330,041	57,288	69,134	64,734	70,322
Long-Term Deferred Tax Assets	48,115	51,020	40,863	35,604	25,074	33,619
Other Long-Term Assets	12,884	-1	-1	-	1	-
Total Assets	1,084,397	1,064,046	913,668	882,437	739,203	746,842
Accounts Payable	63,296	89,329	60,691	66,794	49,689	39,163
Accrued Expenses	-	19,350	13,493	11,726	10,824	10,393
Short-Term Debt	31,642	-	-	-	-	-
Current Portion of Long-Term Debt	-	30,000	-	-	-	-
Current Portion of Leases	2,714	3,178	2,310	2,490	2,301	2,023
Current Income Taxes Payable	18,425	4,319	24,518	40,896	2,284	20,804
Other Current Liabilities	27,188	2,120	2,612	1,023	828	21,350
Total Current Liabilities	143,265	148,296	103,624	122,929	65,926	93,733
Long-Term Debt	82,500	105,000	-	-	-	-
Long-Term Leases	7,574	8,500	6,552	6,678	6,501	7,030
Pension & Post-Retirement Benefits	2,737	2,640	3,294	3,350	3,322	3,056
Long-Term Deferred Tax Liabilities	2,380	10,817	1,013	983	1,009	1,052
Other Long-Term Liabilities	583	591	580	684	771	814
Total Liabilities	239,039	275,844	115,063	134,624	77,529	105,685
Common Stock	17,358	17,358	17,358	17,358	17,358	17,358
Additional Paid-In Capital	-	17,458	17,458	17,080	17,241	17,231
Retained Earnings	825,743	790,908	768,183	709,890	644,754	583,363
Treasury Stock	-62,769	-63,063	-63,233	-54,161	-74,683	-44,705
Comprehensive Income & Other	59,338	19,790	53,195	51,702	51,236	62,300
Total Common Equity	839,670	782,451	792,961	741,869	655,906	635,547
Minority Interest	5,688	5,751	5,644	5,944	5,768	5,610
Shareholders' Equity	845,358	788,202	798,605	747,813	661,674	641,157
Total Liabilities & Equity	1,084,397	1,064,046	913,668	882,437	739,203	746,842
Total Debt	124,430	146,678	8,862	9,168	8,802	9,053
Net Cash (Debt)	64,015	62,368	157,279	86,987	60,370	54,970
Net Cash Growth	286.70%	-60.35%	80.81%	44.09%	9.82%	-10.27%
Net Cash Per Share	136.25	132.76	327.64	178.12	121.58	110.12
Filing Date Shares Outstanding	469.91	469.77	469.65	488.33	488.31	499.21
Total Common Shares Outstanding	469.91	469.77	469.65	488.33	488.24	499.14
Working Capital	290,004	306,808	309,972	222,172	215,340	153,909
Book Value Per Share	1786.88	1665.59	1688.42	1519.18	1343.40	1273.28
Tangible Book Value	448,331	431,224	735,673	672,735	591,172	565,225
Tangible Book Value Per Share	954.08	917.94	1566.44	1377.61	1210.81	1132.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.